Goldman Sachs Group Inc Biotechnology

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$179 Million
282K
Q1 2025
Reduced 26.77%
NVO
Novo Nordisk A S
PUT
$28.4 Million
410K
Q1 2025
Reduced 12.46%
NVO
Novo Nordisk A S
CALL
$20.8 Million
300K
Q1 2025
Reduced 12.46%
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$15.5 Million
24.4K
Q1 2025
Reduced 26.77%
VRTX
Vertex Pharmaceuticals Inc
PUT
$15.1 Million
31.2K
Q1 2025
Reduced 2.29%
BNTX
Bio N Tech Se
CALL
$4.74 Million
52.1K
Q1 2025
Reduced 24.99%
VRTX
Vertex Pharmaceuticals Inc
CALL
$4.56 Million
9.4K
Q1 2025
Reduced 2.29%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$4.32 Million
16K
Q1 2025
Reduced 7.03%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$4.32 Million
16K
Q1 2025
Reduced 7.03%
TVTX
Travere Therapeutics, Inc.
CALL
$3.85 Million
215K
Q1 2025
Reduced 19.86%
SRPT
Sarepta Therapeutics, Inc.
CALL
$3.64 Million
57.1K
Q1 2025
Reduced 38.55%
MRNA
Moderna, Inc.
CALL
$3.53 Million
125K
Q1 2025
Reduced 3.73%
BBIO
Bridge Bio Pharma, Inc.
PUT
$3.46 Million
100K
Q1 2025
Reduced 6.91%
BNTX
Bio N Tech Se
PUT
$3.45 Million
37.9K
Q1 2025
Reduced 24.99%
LEGN
Legend Biotech Corp
PUT
$2.35 Million
69.4K
Q1 2025
Reduced 6.78%
BBIO
Bridge Bio Pharma, Inc.
CALL
$2.25 Million
65K
Q1 2025
Reduced 6.91%
CRVS
Corvus Pharmaceuticals, Inc.
CALL
$1.59 Million
500K
Q1 2025
Reduced 57.58%
ACAD
Acadia Pharmaceuticals Inc
PUT
$1.49 Million
89.8K
Q1 2025
Reduced 7.62%
ACAD
Acadia Pharmaceuticals Inc
CALL
$1.49 Million
89.8K
Q1 2025
Reduced 7.62%
SWTX
Spring Works Therapeutics, Inc.
CALL
$1.32 Million
29.8K
Q1 2025
Reduced 4.54%
VKTX
Viking Therapeutics, Inc.
CALL
$1.09 Million
45K
Q1 2025
Reduced 24.41%
UTHR
United Therapeutics Corp
CALL
$893,000
2.9K
Q1 2025
Reduced 3.66%
PCVX
Vaxcyte, Inc.
PUT
$792,000
21K
Q1 2025
Reduced 3.53%
PCVX
Vaxcyte, Inc.
CALL
$792,000
21K
Q1 2025
Reduced 3.53%
SMMT
Summit Therapeutics Inc.
CALL
$754,000
39.1K
Q1 2025
Reduced 6.39%
ZLAB
Zai Lab LTD
CALL
$643,000
17.8K
Q1 2025
Reduced 19.48%
QURE
Uni Qure N.V.
CALL
$614,000
58K
Q1 2025
Reduced 18.26%
CNTA
Centessa Pharmaceuticals PLC
PUT
$431,000
30K
Q1 2025
Reduced 6.95%
CYTK
Cytokinetics Inc
PUT
$421,000
10.5K
Q1 2025
Reduced 1.42%
CYTK
Cytokinetics Inc
CALL
$365,000
9.1K
Q1 2025
Reduced 1.42%
NTLA
Intellia Therapeutics, Inc.
PUT
$115,000
16.2K
Q1 2025
Reduced 1.32%
NTLA
Intellia Therapeutics, Inc.
CALL
$115,000
16.2K
Q1 2025
Reduced 1.32%
Filter Shares Options
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email